Literature DB >> 31179416

Metastatic retroperitoneal paraganglioma: Case report and review of the literature.

Alexandra L Tabakin1, Michael A Weintraub2, Kushan D Radadia1, Cristo G Salazar3, Evita Sadimin3, Eric A Singer1.   

Abstract

Paragangliomas are rare neuroendocrine tumors with 500 to 1600 new cases in the United States each year (1). The clinical presentation may range from asymptomatic to the classic triad of episodic diaphoresis, headache, and palpitations. Surgery is the hallmark of treatment when tumors are amenable to resection. When patients are found to have metastases, systemic therapies may be employed. In this case report, we present a patient found to have a large retroperitoneal paraganglioma with nodal metastases.

Entities:  

Year:  2019        PMID: 31179416      PMCID: PMC6554718     

Source DB:  PubMed          Journal:  Clin Oncol (Belmont)        ISSN: 2474-1663


  15 in total

1.  The Challenges of Treating Paraganglioma Patients with (177)Lu-DOTATATE PRRT: Catecholamine Crises, Tumor Lysis Syndrome and the Need for Modification of Treatment Protocols.

Authors:  William Makis; Karey McCann; Alexander J B McEwan
Journal:  Nucl Med Mol Imaging       Date:  2015-04-09

2.  Clinical benefits of systemic chemotherapy for patients with metastatic pheochromocytomas or sympathetic extra-adrenal paragangliomas: insights from the largest single-institutional experience.

Authors:  Montserrat Ayala-Ramirez; Lei Feng; Mouhammed A Habra; Thereasa Rich; Paxton V Dickson; Nancy Perrier; Alexandria Phan; Steven Waguespack; Shreyaskumar Patel; Camilo Jimenez
Journal:  Cancer       Date:  2011-10-17       Impact factor: 6.860

Review 3.  Treatment for Malignant Pheochromocytomas and Paragangliomas: 5 Years of Progress.

Authors:  Paola Jimenez; Claudio Tatsui; Aaron Jessop; Sonali Thosani; Camilo Jimenez
Journal:  Curr Oncol Rep       Date:  2017-10-28       Impact factor: 5.075

Review 4.  (131)I-MIBG therapy for malignant paraganglioma and phaeochromocytoma: systematic review and meta-analysis.

Authors:  L T van Hulsteijn; N D Niemeijer; O M Dekkers; E P M Corssmit
Journal:  Clin Endocrinol (Oxf)       Date:  2013-11-19       Impact factor: 3.478

5.  A rare case of retroperitoneal paraganglioma-case report and literature review.

Authors:  Peng Li; Dongbing Zhao
Journal:  Transl Gastroenterol Hepatol       Date:  2016-07-18

6.  Pheochromocytoma of the Adrenal gland Scaled Score (PASS) to separate benign from malignant neoplasms: a clinicopathologic and immunophenotypic study of 100 cases.

Authors:  Lester D R Thompson
Journal:  Am J Surg Pathol       Date:  2002-05       Impact factor: 6.394

7.  Treatment with sunitinib for patients with progressive metastatic pheochromocytomas and sympathetic paragangliomas.

Authors:  Montserrat Ayala-Ramirez; Cecile N Chougnet; Mouhammed Amir Habra; J Lynn Palmer; Sophie Leboulleux; Maria E Cabanillas; Caroline Caramella; Pete Anderson; Abir Al Ghuzlan; Steven G Waguespack; Desirée Deandreis; Eric Baudin; Camilo Jimenez
Journal:  J Clin Endocrinol Metab       Date:  2012-09-10       Impact factor: 5.958

8.  Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline.

Authors:  Jacques W M Lenders; Quan-Yang Duh; Graeme Eisenhofer; Anne-Paule Gimenez-Roqueplo; Stefan K G Grebe; Mohammad Hassan Murad; Mitsuhide Naruse; Karel Pacak; William F Young
Journal:  J Clin Endocrinol Metab       Date:  2014-06       Impact factor: 5.958

Review 9.  15 YEARS OF PARAGANGLIOMA: Clinical manifestations of paraganglioma syndromes types 1-5.

Authors:  Diana E Benn; Bruce G Robinson; Roderick J Clifton-Bligh
Journal:  Endocr Relat Cancer       Date:  2015-08       Impact factor: 5.678

10.  Validation of pathological grading systems for predicting metastatic potential in pheochromocytoma and paraganglioma.

Authors:  Jung-Min Koh; Seong Hee Ahn; Hyeonmok Kim; Beom-Jun Kim; Tae-Yon Sung; Young Hoon Kim; Suck Joon Hong; Dong Eun Song; Seung Hun Lee
Journal:  PLoS One       Date:  2017-11-08       Impact factor: 3.240

View more
  2 in total

1.  Abdominal paraaortic paraganglioma: Management of intraoperative hemodynamic emergencies during elective resection procedures (A case presentation).

Authors:  Ovidiu Stiru; Anca Dragan; Cristina Adamache; Petru Razvan Dragulescu; Carmen Stiru; Adrian Tulin; Nicolae Bacalbasa; Irina Balescu; Camelia Diaconu; Roxana Carmen Geana; Cornel Savu; Vlad Anton Iliescu
Journal:  Exp Ther Med       Date:  2021-03-23       Impact factor: 2.447

2.  Huge Right Retroperitoneal Paraganglioma With a High Risk of Surgical Excision Treated Conservatively for 14 Years.

Authors:  Rania Naguib
Journal:  Cureus       Date:  2022-01-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.